摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-(2-hydroxyethoxymethyl)guanine phosphorodipyrrolidate | 1380398-79-7

中文名称
——
中文别名
——
英文名称
9-(2-hydroxyethoxymethyl)guanine phosphorodipyrrolidate
英文别名
9-(2-Hydroxyethoxymethyl)Guanine, Phosphorodipyrrolidate;2-amino-9-(2-dipyrrolidin-1-ylphosphoryloxyethoxymethyl)-1H-purin-6-one
9-(2-hydroxyethoxymethyl)guanine phosphorodipyrrolidate化学式
CAS
1380398-79-7
化学式
C16H26N7O4P
mdl
——
分子量
411.401
InChiKey
DXFPCZFZIHJYJU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    657.3±65.0 °C(Predicted)
  • 密度:
    1.66±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.6
  • 重原子数:
    28
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.69
  • 拓扑面积:
    127
  • 氢给体数:
    2
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    9-(2-hydroxyethoxymethyl)guanine phosphorodipyrrolidate 在 potassium chloride 、 potassium hydroxide 作用下, 以 为溶剂, 反应 0.08h, 生成 阿昔洛韦
    参考文献:
    名称:
    Phosphoramidate derivatives of acyclovir: Synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro
    摘要:
    The antiviral activity against HIV and HSV and the chemical stability of ACV phosphoramidate derivatives were studied. The phosphoramidates of ACV demonstrated moderate activity. The best compound appeared to be 9-(2-hydroxymethyl)guanine phosphoromonomorpholidate (7), which inhibited virus replication in pseudo-HIV-1 particles by 50% at 50 mu M. It also inhibited replication of wild-type HSV-1 (9.7 mu M) as well as an acyclovir-resistant strain (25 mu M). None of the synthesised compounds showed any cytotoxicity. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.08.008
  • 作为产物:
    描述:
    参考文献:
    名称:
    Phosphoramidate derivatives of acyclovir: Synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro
    摘要:
    The antiviral activity against HIV and HSV and the chemical stability of ACV phosphoramidate derivatives were studied. The phosphoramidates of ACV demonstrated moderate activity. The best compound appeared to be 9-(2-hydroxymethyl)guanine phosphoromonomorpholidate (7), which inhibited virus replication in pseudo-HIV-1 particles by 50% at 50 mu M. It also inhibited replication of wild-type HSV-1 (9.7 mu M) as well as an acyclovir-resistant strain (25 mu M). None of the synthesised compounds showed any cytotoxicity. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.08.008
点击查看最新优质反应信息

文献信息

  • Phosphoramidate derivatives of acyclovir, inhibitors of herpes virus replication
    作者:N. F. Zakirova、A. V. Shipitsyn、M. V. Jasko、S. N. Kochetkov
    DOI:10.1134/s1068162011050190
    日期:2011.9
    A series of new acyclovir phosphoramidates-potential antiviral agents against resistant strains of herpes virus-was synthesized. Of several approaches used for their synthesis, the treatment of the intermediate phosphorochloridate with various amines proved to be optimal. Two of the synthesized compounds were moderately active against HSV-1.
  • Phosphoramidate derivatives of acyclovir: Synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro
    作者:Natalia F. Zakirova、Alexander V. Shipitsyn、Maxim V. Jasko、Maria M. Prokofjeva、Valeria L. Andronova、Georgiy A. Galegov、Vladimir S. Prassolov、Sergey N. Kochetkov
    DOI:10.1016/j.bmc.2012.08.008
    日期:2012.10
    The antiviral activity against HIV and HSV and the chemical stability of ACV phosphoramidate derivatives were studied. The phosphoramidates of ACV demonstrated moderate activity. The best compound appeared to be 9-(2-hydroxymethyl)guanine phosphoromonomorpholidate (7), which inhibited virus replication in pseudo-HIV-1 particles by 50% at 50 mu M. It also inhibited replication of wild-type HSV-1 (9.7 mu M) as well as an acyclovir-resistant strain (25 mu M). None of the synthesised compounds showed any cytotoxicity. (C) 2012 Elsevier Ltd. All rights reserved.
查看更多